Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Intercept Pharmaceuticals Inc (was acquisited by Alfasigma (Italy) on 08/11/2023) (ICPT)

  • Event
  • Aug. 03, 2022, 11:00 UTC
  • 12
  • 1 comments

(10% Negative) Intercept Pharmaceuticals, Inc. (ICPT) Reports Q3 2022 Financial Results

Comment Full text

Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF)

  • Event
  • Aug. 03, 2022, 10:51 UTC
  • 12
  • 1 comments

(30% Negative) Surface Oncology Inc (was by Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) on 16/06/2023) (SURF) Reports Q3 2022 Financial Results

Comment Full text

Editas Medicine Inc (EDIT)

  • Event
  • Aug. 03, 2022, 10:46 UTC
  • 12
  • 1 comments

(30% Negative) Editas Medicine, Inc. (EDIT) Reports Q3 2022 Financial Results

Comment Full text

G1 Therapeutics Inc (GTHX)

  • Event
  • Aug. 03, 2022, 10:35 UTC
  • 12
  • 1 comments

(30% Negative) G1 THERAPEUTICS, INC. (GTHX) Reports Q3 2022 Financial Results

Comment Full text

United Therapeutics Corporation (UTHR)

  • Event
  • Aug. 03, 2022, 10:06 UTC
  • 12
  • 1 comments

(75% Positive) United Therapeutics Corporation (UTHR) Announces Enrollment Update for usefulness Due to Patient Enrollment Issues, Manufacturing Considerations

Comment Full text

Edgewise Therapeutics Inc. (EWTX)

  • Event
  • Aug. 03, 2022, 05:01 UTC
  • 90
  • 0 comments

Edgewise Therapeutics - Wedbush PacGrow Healthcare Conference

Comment Full text

Moderna Inc (MRNA)

  • Event
  • Aug. 03, 2022, 05:00 UTC
  • 147
  • 0 comments

Moderna - Corporate Presentation

Comment Full text

Castle Biosciences Inc (CSTL)

  • Event
  • Aug. 03, 2022, 04:01 UTC
  • 93
  • 0 comments

Castle Biosciences - Canaccord Genuity 42nd Annual Growth Conference

Comment Full text

Aclaris Therapeutics Inc (ACRS)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 10
  • 1 comments

(28% Negative) Aclaris Therapeutics, Inc. (ACRS) Reports Net Loss for 2022-06-30

Comment Full text

Veracyte Inc (VCYT)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 10
  • 1 comments

(28% Negative) VERACYTE, INC. (VCYT) Reports 112% Loss Increase for 2022-06-30

Comment Full text
  • Previous
  • 140
  • 141
  • 142
  • 143
  • 144
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189345)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124574)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin